Grant: Operating Grant
McMaster University
$100,000.00
The Role of the Hexosamine Biosynthesis Pathway in Diabetes-Induced Accelerated Atherosclerosis
EF 2014-15
Résumé
The incidence of diabetes is increasing rapidly across Canada and around the world. Three out of every four people with diabetes will die prematurely of heart attack or stroke.
The ultimate goals of our research are;
1.to determine why this is, and
2.to find ways to prevent this from happening.
We have established unique cell and animal model systems to attain these goals. Using these systems we have recently found that high levels of sugar in the blood (hyperglycemia) can damage to the cells of the blood vessel walls. Specifically, the blood vessel cells take in the glucose and convert it to a compound called glucosamine. It appears that the high level of glucosamine is responsible for the vessel damage. In fact, when we give high levels of glucosamine to a mouse, we can induce atherosclerosis - a major underlying cause of heart attack and stroke. Our results suggest that if we can block the conversion of glucose to glucosamine, or if we can block the effects of glucosamine on the cells, that we can protect the blood vessels from atherosclerosis in our diabetic models.
The experiments described in this grant proposal are designed to increase our understanding of this potentially important mechanism in cells and mouse models. We are especially interested in finding new targets that can be used to block disease progression. These studies are important because they are examining new and potentially more effective strategies to treat and/or prevent the cardiovascular complications of diabetes.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
313981
Name
Werstuck Geoffrey H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
The Role of the Hexosamine Biosynthesis Pathway in Diabetes-Induced Accelerated Atherosclerosis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Atherosclerosis; Diabetes Mellitus; Endoplasmic Reticulum Stress; Glutamine:Fructose-6 Phosphate Amidotransferase; Mouse Models
Abstract
The incidence of diabetes is increasing rapidly across Canada and around the world. Three out of every four people with diabetes will die prematurely of heart attack or stroke.
The ultimate goals of our research are;
1.to determine why this is, and
2.to find ways to prevent this from happening.
We have established unique cell and animal model systems to attain these goals. Using these systems we have recently found that high levels of sugar in the blood (hyperglycemia) can damage to the cells of the blood vessel walls. Specifically, the blood vessel cells take in the glucose and convert it to a compound called glucosamine. It appears that the high level of glucosamine is responsible for the vessel damage. In fact, when we give high levels of glucosamine to a mouse, we can induce atherosclerosis - a major underlying cause of heart attack and stroke. Our results suggest that if we can block the conversion of glucose to glucosamine, or if we can block the effects of glucosamine on the cells, that we can protect the blood vessels from atherosclerosis in our diabetic models.
The experiments described in this grant proposal are designed to increase our understanding of this potentially important mechanism in cells and mouse models. We are especially interested in finding new targets that can be used to block disease progression. These studies are important because they are examining new and potentially more effective strategies to treat and/or prevent the cardiovascular complications of diabetes.
Competitiondate
201405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Werstuck, Geoffrey H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~